Abstract
The primary outcome measure was pain in the worse knee, recorded on a 10 cm visual analogue scale in the presence of BQ. We used the function subscale of the Western Ontario and McMaster Universities' osteoarthritis index (WOMAC), a validated, disease specific, patient based measure, as a secondary outcome measure.5 An experienced interviewer undertook the in-depth interviews after the treatment but before the main follow up visit of the trial. Interviews were conducted in patients' homes, guided by a checklist of topics that ensured similar issues were explored. Interviews were taped, fully transcribed, and analysed independently by RC and PD, who were blind to the scores on the scales. For both questionnaire and interview data we recorded whether the patient reported worsening, improvement, or no change in pain and restriction of activities.